All In MedTech

FDA Clearance Tracker · K190575

iBreastExam

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Jul 16, 2019 (this decision)Source: openFDAMethods & limitations

510(k)

The decision

FDA number
K190575
Device name
iBreastExam
Applicant location
Philadelphia, PA
Received
Mar 6, 2019
Decided
Jul 16, 2019
Decision
Substantially Equivalent
Submission type
Abbreviated

Device type

Device class
Class II
Regulation
21 CFR 884.2990

Every decision under product code NKA

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NKA. The earliest in FDA's data is DEN020001, decided Jan 31, 2003.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Ue Lifesciences, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.